Dr. Rebecca Ahrens-Nicklas is an Assistant Professor of Pediatrics in the Division of Human Genetics and Metabolism at Children’s Hospital of Philadelphia (CHOP) and the University of Pennsylvania. After completing MD/PhD training in Physiology and Biophysics, she pursued clinical training in Pediatrics, Clinical Genetics, and Metabolism. She cares for children with rare diseases, with a special interest in neurometabolic disorders. Her research laboratory focuses both on gene discovery and elucidating the pathologic mechanisms underlying rare diseases to guide therapy development. She also partners with advocacy groups to conduct natural history and biomarker studies to promote clinical trial readiness for these rare conditions.
How Scientists Made The First Gene-Editing Treatment For A Baby
Last month, a baby got the world’s first personalized gene-editing treatment. What will this mean for the millions of others with genetic diseases?